MentionFox
Home › funding signals › Matthias Therapeutics, LLC
Form D · on the record

Matthias Therapeutics — $50K Form D filing, June 2026

Matthias Therapeutics, LLC filed a Form D with the Securities and Exchange Commission on 2026-06-01.

Get the full cited report on Matthias Therapeutics, LLC

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

See a sample report

Just raised? Share it.

Matthias Therapeutics, LLC: Raised $50K, Form D filed 2026-06-01

What do you want to do with Matthias Therapeutics, LLC?

Key facts

  • · Form D filed with the SEC · Form D
  • · Sold to date: $50K · Form D
  • · Total offering: $500K · Form D
  • · First sale: 2026-05-14 · Form D
  • · Investors already in: 1 · Form D

Matthias Therapeutics, LLC

New Form D on file · 2026-06-01 · the record

$50K
raise on the record
D
filing
1
investors in
NEW JERSEY
based
Open the record →

What the record says

FilingForm D
Filed2026-06-01
Industry groupPharmaceuticals
Entity typeLimited Liability Company
Incorporated inDELAWARE
Year formed2023
BasedBASKING RIDGE, NEW JERSEY
CIK2104165
Accession0002104165-26-000003
Filing history · 2 filings on this registrant
Form D · 2026-01-07 · $100KForm D · 2026-06-01 · $50K · this page 2026-01-07 2026-06-01

Each marker is one filing. The larger marker is the filing this page is about.

Pharmaceuticals · by week
This raise, $50K, filed week of Jun 1

Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $50K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Matthias Therapeutics, LLC?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Matthias Therapeutics, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Matthias Therapeutics, LLC covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Matthias Therapeutics, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Matthias Therapeutics, LLC. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/matthias-therapeutics-llc-form-d-26000001
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
Matthias Therapeutics raised $50K — SEC Form D filing, June 2026. MentionFox, 2026-09-26. https://mentionfox.com/funding/matthias-therapeutics-llc-form-d-26000001